Individualized Exercise Prescription With a Data-driven Approach in Individuals With Stroke
1 other identifier
interventional
52
1 country
1
Brief Summary
The goal of this clinical trial is to evaluate if the exercised via data-driven approach is effective in enhance the gait pattern in people with stroke. It will reduce burdun of patient consultations for clinicians in reality.The main questions it aims to answer are: Does individualized exercise training programmes via data-driven approach could improve gait patterns in individuals with chronic stroke? Does individualized exercise training programmes via data-driven approach could improve improve motor recovery, motor functions (including gait speed and balance performance), and community integration in individuals with chronic stroke? Participants will: Undergo 12 supervised-exercise (training sessions (60 minutes, two times a week, for six weeks), Participants will receive a data-driven exercise prescription or conventional exercise prescription which consists of 5 different exercises. They will be assessed on Baseline assessment before training (A0); after six sessions (A1); after 12 sessions (A2); and three months after training (A3).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jul 2024
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2024
CompletedFirst Submitted
Initial submission to the registry
March 3, 2025
CompletedFirst Posted
Study publicly available on registry
March 17, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
October 31, 2026
September 15, 2025
September 1, 2025
2 years
March 3, 2025
September 8, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Gait kinematics
Seventeen wearable sensors (Inertial Measurement Units, IMUs) were attached to the participants' bodies in accordance with the Xsens user manual to collect kinematic data. The extracted data included the pelvis tilt angle (°), oblique angle (°), and rotation angle (°); hip flexion angle (°) and abduction angle (°); knee bending angle (°); as well as ankle flexion angle (°) and abduction angle (°), which were used for further analysis. These data were converted into standardized gait cycles (101 time points) for statistical parametric mapping (SPM1D) analysis, and the deviation time from the normal reference was compared to determine whether there were changes in deviation timing before and after the treatment.
At baseline and 6 weeks post-intervention
Secondary Outcomes (8)
Electromyography (EMG) signals in Maximum Voluntary Contraction (MVC) and muscle activation during gait
At baseline and 6 weeks post-intervention
Fugl-Meyer assessment (FMA-LE)
At baseline and 6 weeks post-intervention
Berg Balance Scale (BBS)
At baseline and 6 weeks post-intervention
Subjective Index of physical and Social Outcome (SIPSO)
At baseline and 6 weeks post-intervention
Short Physical Performance Battery (SPPB)
At baseline and 6 weeks post-intervention
- +3 more secondary outcomes
Study Arms (2)
Data-driven exercise group
EXPERIMENTALBased on the results of the gait patterns, the PI will design appropriate exercises that target the specific gait impairment at a specific time period during the gait cycle. Exercises will utilize various modalities that are commonly used in clinical practice, including TheraBand, gym equipment, free weight. The training may target single-joint movement or targeting a movement pattern that involves multiple joint holistically. A body harness system will be used to protect the participant during the exercise training. The participant will be supervised by a research assistant who has rich experience in conducting exercise training on people with disability.
Standarzied exercise group
PLACEBO COMPARATORParticipants in the standard exercise group will undergo a standardised exercise programme consisting of five lower-limb exercises commonly employed in clinical settings and prescribed to patients as home exercises. They include (1) stepping up and down to strengthen the muscles of both legs and to improve control in shifting the center of gravity; (2) heel-raising exercises on an inclined wedge to strengthen both ankle plantarflexors; (3) assuming a semi-squatting position to improve lower-limb muscle endurance and proprioception in the knees and ankles; (4) standing on a dura disk to improve dynamic standing balance; (5) walking across obstacles to enhance anticipatory postural control.
Interventions
The result from the Statistical Parametric Mapping 1D (SPM1D) analysis will be used to identify the magnitude of deviation from normal gait patterns in reference to healthy subjects for each lower limb joint. Thereby, the targeted action and joint position can be identified. Training will focus on the specific movement where the "steepest gradients" are observed. The targeted exercises will be selected based on the five largest deviations observed during the swing or stance phase. Open-chain exercises will be applied to address deviations in the swing phase, while closed-chain exercises will be applied to address deviation in the stance phase. Each exercise will be performed for approximately 80-100 repetitions, with a total duration of 10 minutes per exercise, including rest periods.
The participants will perform dose match standardised exericse program.
Eligibility Criteria
You may qualify if:
- between 45 and 75 years old;
- have received a diagnosis of stroke more than six months earlier;
- able to walk 10 m independently;
- able to score at least 6 of 10 on the Abbreviated Mental Test;
- able to follow instructions and give informed consent.
You may not qualify if:
- any existing medical condition such as uncontrolled hypertension that hindered training or assessment;
- unable to offer consent due to impaired cognitive function.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
the Hong Kong Polytechnic University
Hksar, Hong Kong
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
March 3, 2025
First Posted
March 17, 2025
Study Start
July 1, 2024
Primary Completion (Estimated)
June 30, 2026
Study Completion (Estimated)
October 31, 2026
Last Updated
September 15, 2025
Record last verified: 2025-09
Data Sharing
- IPD Sharing
- Will not share
Individual participant data will not be shared to other researchers